FRANKFURT--The following is a summary of analysts' forecasts for
Fresenius Medical Care AG & Co. KGaA (FMS) second-quarter
results, based on a poll of seven analysts conducted by Dow Jones
Newswires (figures in million dollars, EPS in dollar, dividend and
target price in euro, according to US-GAAP). Earnings figures are
scheduled to be released July 31.
===
Net
Net attrib. EPS basic
2nd Quarter Revenue EBIT income ord.share
AVERAGE 3,748 528 248 0.82
Prev. Year 3,615 544 263 0.86
+/- in % +3.7 -2.9 -5.6 -4.5
MEDIAN 3,778 532 250 0.83
Maximum 3,810 544 262 0.87
Minimum 3,660 504 232 0.77
Amount 7 7 7 7
Berenberg 3,810 544 252 0.83
Credit Suisse 3,780 544 262 0.87
Deutsche Bank 3,778 536 249 0.82
Equinet 3,717 525 252 0.83
Helvea 3,713 514 241 0.80
Kepler Cheuvreux 3,779 532 250 0.83
Warburg Research 3,660 504 232 0.77
Target price Rating DPS 2014
AVERAGE 56.31 positive 5 AVERAGE 0.81
Prev. Quarter 56.65 neutral 3 Prev. Year 0.77
+/- in % -0.6 negative 0 +/- in % +5.5
MEDIAN 57.00 MEDIAN 0.83
Maximum 61.00 Maximum 0.85
Minimum 48.50 Minimum 0.75
Amount 8 Amount 4
Berenberg 56.00 Hold 0.75
Commerzbank 61.00 Buy --
Credit Suisse 56.00 Outperform --
Deutsche Bank 48.50 Hold --
Equinet 58.00 Buy --
Helvea 55.00 Hold 0.80
Kepler Cheuvreux 58.00 Buy 0.85
Warburg Research 58.00 Buy 0.85
===
Year-earlier figures are as reported by the company.
DJG/mus
Subscribe to WSJ: http://online.wsj.com?mod=djnwires